Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study항암 치료를 받는 고형암 환자에서 BNT162b2 백신 접종의 유효성 및 안전성 - 단일 센터 전향적 연구Article Published on 2021-11-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome Adequate adverse events Analysis Antibody Response anticancer BNT162b2 Cancer Chemotherapy co-morbidities combinations Comorbidity conducted Control controls Coronavirus-2 COVID19 dose Efficacy evaluate evaluated first dose Frequency health-care IgG immune response Immunoglobulin Immunotherapy increased risk neutralising antibody of BNT162b2 oncology Patient patients Patients with cancer predictor Prospective Study Radiotherapy RBD receiving SARS-CoV-2 second dose seronegative Seronegativity Seropositivity severe coronavirus disease severity significantly more solid cancer solid tumour the receptor-binding domain therapy titre treated Treatment vaccination Vaccine vaccine dose were given were measured [DOI] 10.1016/j.ejca.2021.08.007 PMC 바로가기 [Article Type] Article
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in ItalyResearch article Published on 2021-11-012022-10-05 Journal: European journal of cancer (Oxford, England : 1990 [Category] SARS, 치료법, [키워드] administration antibodies antibody anticancer anticancer treatment baseline BNT162b2 Cancer cancer patient Cancer patients cancer progression composed conducted consecutive patient control group coronavirus disease COVID-19 COVID-19 antibody COVID-19 infection COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine evaluate evaluated Factor GRADE healthy volunteers high risk IgG IgG titer immunogenic Italy Male sex median median age metastatic disease Patient prospective observational study receive reported Result RNA-1273 safety profile SARS-CoV-2 second dose secondary Seroconversion Seropositivity serum sample Side-effects significantly lower solid cancer solid tumour the vaccine therapy Treatment tumour two-dose regimen vaccination Vaccine vaccine dose were excluded [DOI] 10.1016/j.ejca.2021.08.035 [Article Type] Research article
The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience청소년 및 암에 걸린 젊은 성인을 위한 BNT162b2 mRNA COVID-19 백신: 단일 중심 경험Comparative Study Published on 2021-09-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] MERS, 신약개발, 진단, [키워드] Administered administration Affect antibody AYA BNT162b2 mRNA Cancer Care COVID COVID-19 COVID-19 infection COVID-19 vaccine Critical determine Efficacy IgG IgG antibody Immunoglobulin include infections injection Local mandatory median Mild neutralisation neutralisation test oncology one patient Paediatric oncology paediatric patient Pain Patient patients positive COVID-19 positive serology pre-vaccination progression reactivity Retrospective analysis S1 domain safety profile Seroconversion serology serology testing Side-effect solid tumour Symptom systemic symptom tested the spike protein the vaccine Treatment Tumours vaccination Vaccine vaccine injection was tested were given [DOI] 10.1016/j.ejca.2021.06.002 PMC 바로가기 [Article Type] Comparative Study
Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendationsResearch article Published on 2021-08-012022-10-05 Journal: Journal of Bone Oncology [Category] 치료법, [키워드] access to treatment addition administration affected Analysis bisphosphonate Bisphosphonates bone Bone health Bone metastasis Breast cancer Cancer cancer treatment Care clinician Clinicians Complete country COVID-19 COVID-19 pandemic CT scan Delay Denosumab disease Drug administration Effect Frequency Health hospital impacted include International intravenous Laboratory less Local majority management Melanoma Metastasis MRI offered Oncologists Optimum Pain pandemic Participants Patient Patients with cancer Perspective Prophylactic proportion Prostate questionnaire Radiotherapy recommendation reduced renal reported Research respondent risk significantly single dose Society solid tumour Spread Standard of care Support switching therapy Treatment USA Zoledronic acid [DOI] 10.1016/j.jbo.2021.100375 [Article Type] Research article
Systematic SARS-CoV-2-testing for asymptomatic cancer patients treated at a public healthcare tertiary centre in BrazilShort Communication Published on 2021-07-262022-10-31 Journal: ecancermedicalscience [Category] COVID-19, [키워드] acute respiratory syndrome adherent affected age anticancer Asymptomatic asymptomatic patient Asymptomatic testing base Brazil Cancer cancer patient carried Characteristics Chemotherapy Cohort Complication consequence coronavirus coronavirus disease COVID-19 demographic demonstrated determine Eligible patients enrolled female gastrointestinal tract healthcare higher risk highest hospital hygiene hypothesise increased risk independent Infection means Measures median metastatic disease Most patient nasal oropharyngeal swab outcome pandemic Patient patients Patients with cancer physical distancing polymerase chain positive pre-symptomatic Prevalence prevalence of COVID-19 proportions public health receiving Result RNA severe disease solid cancer solid tumour tested therapy Transmissibility treated Treatment were excluded white [DOI] 10.3332/ecancer.2021.1269 PMC 바로가기 [Article Type] Short Communication
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in JapanObservational Study Published on 2021-06-152022-10-05 Journal: BMJ Open [Category] Coronavirus, SARS, 임상, [키워드] Admission analyses cardiovascular disease cerebrovascular chronic respiratory disease Comorbidity contributing to COVID-19 death diabetes diagnostic test dialysis disease Epidemiology Factor Factors fatality healthcare hospital hospitalisation hypertension In-hospital Japan Japanese large cohort Liver disease may be propelled mechanical ventilation membrane men Mild obesity Observational cohort study Older age outcome oxygen Oxygen therapy Oxygenation participant patients with COVID-19 positive test result progression Registered renal respiratory rate risk factor SARS-CoV-2 secondary secondary outcome severity solid tumour SpO2 the disease Virology [DOI] 10.1136/bmjopen-2020-047007 PMC 바로가기 [Article Type] Observational Study
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia중증 급성 호흡기 증후군 코로나 바이러스 -2 (SARS -COV -2)에 대한 BNT162B2 mRNA 백신의 단일 용량은 만성 골수 백혈병 환자에서 중화 항체 및 다항식 T- 세포 반응을 유도합니다.Clinical Trial Published on 2021-06-032022-08-13 Journal: British Journal of Haematology [Category] MERS, SARS, 임상, 진단, 치료제, [키워드] acute respiratory syndrome addition anti‐Spike immunoglobulin G BNT162b2 BNT162b2 vaccine CD4 CD8 Cellular immune response chronic myeloid leukaemia clinically CML develop Dilution dose evaluated haematological malignancies haematological malignancy humoral Humoral and cellular immune responses immune response immune responses immunocompromised individual immunocompromised individuals immunogenicity Immunoglobulin Immunoglobulin G induce Infection inhibit injection kinase inhibitors lymphoid haematological malignancies medium Most patients mRNA vaccine myeloid leukaemia Neutralising Antibodies neutralising antibody neutralising antibody response nine of BNT162b2 Patient patients Pfizer‐BioNTech polyfunctional response polyfunctional responses raised receiving respiratory SARS‐CoV‐2 SARS‐CoV‐2 BNT162b2 SARS‐CoV‐2 BNT162b2 vaccine SARS‐CoV2 vaccine Seroconversion serum dilution Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus single dose solid and haematological malignancies solid tumour T‐cell T‐cell response targeted cancer treatment targeted cancer treatments the patient These data titre TKIs tyrosine tyrosine kinase inhibitor tyrosine kinase inhibitors vaccination Vaccine were assessed [DOI] 10.1111/bjh.17568 PMC 바로가기 [Article Type] Clinical Trial
Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors고형 종양 및 관련 인자가 있는 환자에서 연장된 SARS-CoV-2 바이러스 배출Article Published on 2021-05-012022-09-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] MERS, SARS, 진단, 치료제, [키워드] Factor Patient Prolonged SARS-CoV-2 viral shedding solid tumour [DOI] 10.1016/j.ejca.2021.02.011 PMC 바로가기 [Article Type] Article
Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial testsSARS-CoV-2에 대한 면역글로불린 G/총 항체 검사: 3개의 상용 검사를 비교하는 2개의 벨기에 종양학 병동의 보행 환자 및 의료 종사자에 대한 전향적 코호트 연구Comparative Study Published on 2021-05-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] MERS, SARS, 진단, [키워드] Abbott absolute value added ambulatory patient antibody Antibody testing Antwerp Better Cancer cancer patient Cancer patients coronavirus 2 correlated COVID-19 Diagnosis DiaSorin disease First wave Fisher Ghent HCW Health care Health care worker health care workers healthy volunteers hematological high risk humoral immune response immune response Immunoglobulin G individual Infection knowledge management median much lower negative test not differ oncology pandemic participated Patient polymerase chain positive positive RT-PCR prospective cohort study rate of seroconversion remained respiratory Roche RT-PCR SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antibody test SARS-CoV-2 IgG SARS-CoV-2 RT-PCR Seroconversion Seroprevalence significantly solid tumour study period study population the patient Treatment tumour unit university vaccination was measured were used [DOI] 10.1016/j.ejca.2021.02.024 PMC 바로가기 [Article Type] Comparative Study
COVID‐19 outbreak: An experience to reappraise the role of hospital at home in the anti‐cancer drug injectionOriginal Research Published on 2021-03-052022-10-31 Journal: Cancer Medicine [Category] COVID-19, MERS, SARS, [키워드] adjusted Administered administration Breast cancer Cancer cancer patient cancer treatment Care Characteristics classical COVID‐19 COVID‐19‐Organisation decrease described develop drug eligibility criteria French haematological malignancy Health Health Service home home‐based hospital hospital Immunotherapy injection Injections lockdown management oncology outbreak pandemic Patient patients treated public health Radiotherapy remained resource Result risk solid tumour the patient Transmission Travel treated patients Treatment [DOI] 10.1002/cam4.3682 PMC 바로가기 [Article Type] Original Research